MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CDIO — Cardio Diagnostics Holdings Inc. Common stock
NasdaqCardio Diagnostics Holdings Inc. Common stock
$1.96
+0.04(+2.08%)
- O
- 1.97
- H
- 1.97
- L
- 1.86
- V
- 26.12K
⏱️ End-of-day dataAs of Oct 2, 2026
Cardio Diagnostics Holdings Inc. Common stock Statistics
Total Valuation
| Market Cap | $5.77M |
| Enterprise Value | $5.76M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 2.96M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3,223.74 |
| EV / Sales | n/a |
| EV / EBITDA | -3,410.68 |
| EV / EBIT | -3,229.16 |
| EV / FCF | -3,544.93 |
Financial Position
| Current Ratio | 15.77 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.10 |
| Debt / FCF | -0.10 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | -20.08% |
| Return on Assets (ROA) | -18.70% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-105 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | $0 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -53.88% |
| 50-Day Moving Average | $1.88 |
| 200-Day Moving Average | $2.17 |
| Relative Strength Index (RSI) | 37.21 |
| Average Volume (20 Days) | 32,304 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -$1.78K |
| Pretax Income | -$1.79K |
| Net Income | -$1.79K |
| EBITDA | -$1.69K |
| EBIT | -$1.78K |
| Loss Per Share | $-0.63 |
Balance Sheet
| Cash & Cash Equivalents | $7.08K |
| Total Debt | $165 |
| Net Cash | $6.91K |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | $8.90K |
| Book Value Per Share | $0.00 |
| Working Capital | $7.25K |
Cash Flow
| Operating Cash Flow | -$1.73K |
| Capital Expenditures | -$-2 |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -$1.63K |
| FCF Per Share | $-0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | -0.03% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |